Mc Adam, LLC Vaxxinity, Inc. Transaction History

Mc Adam, LLC

  • $1.65 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024
BUY
$0.7 - $1.31 $7,000 - $13,100
10,000 Added 14.65%
78,281 $66,000
Q3 2023

Oct 31, 2023
BUY
$1.25 - $3.0 $27,446 - $65,871
21,957 Added 47.4%
68,281 $93,000
Q1 2023

Apr 24, 2023
BUY
$1.43 - $4.24 $66,243 - $196,413
46,324 New
46,324 $105,000

Others Institutions Holding VAXX

# of Institutions
9
Shares Held
469K
Call Options Held
0
Put Options Held
0
View Full List

About Vaxxinity, Inc.

VAXX Quotes by TradingView
  • Ticker VAXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 112,150,000
  • Market Cap $1.12M
  • Description
  • Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...
More about VAXX
Track This Portfolio

Track Mc Adam, LLC Portfolio

Follow Mc Adam, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Adam, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Adam, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email